Dorothea Sesardic - Concepedia

Author

Dorothea Sesardic

National Institute for Biological Standards and Control

Also Known As

D SESARDIC, D Sesardic, D. SESARDIC, D. Sesardic, DOROTHEA SESARDIC, Dorothea Sesardic, Dorothea Thea Sesardic, Sesardic Dorothea

147

Publications

Citations

H-Index

118

Concepts

All Affiliations

National Institute for Biological Standards and Control London Postgraduate Medical and Dental Education Technische Universität Braunschweig ETH Zurich

About

Dorothea Sesardic is an author at National Institute for Biological Standards and Control specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	65	2.7K
2	Natural Sciences	7	7	230
3	Health Sciences	5	5	348
4	Education	3	3	72
5	Engineering	2	2	275

Dorothea Sesardic

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man. Dorothea Sesardic, B. P. Murray, Sandra Murray, British Journal of Clinical Pharmacology	1990	280
A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O‐deethylation of phenacetin and is inducible by cigarette smoking. Dorothea Sesardic, RJ Edwards, DS Davies British Journal of Clinical Pharmacology	1988	235
Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery Burak Sayın, Satyanarayana Somavarapu, XW Li, International Journal of Pharmaceutics NanoparticlesNanomedicineVaccinationEngineeringImmunology	2008	177
Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation Frédéric A. Meunier, Godfrey Lisk, Dorothea Sesardic, Molecular and Cellular Neuroscience Peripheral Nerve InjurySnap-25 TruncationTerminal RemodelingSnare-cleaving Botulinum ToxinsMotor Control	2003	156
Diphtheria immunity in UK blood donors P.A.C. Maple, Androulla Efstratiou, Robert C. George, The Lancet VaccinationHematologyImmunologyBlood TransplantationUk Blood Donors	1995	115
Differential expression and regulation of members of the cytochrome P450IA gene subfamily in human tissues Dorothea Sesardic, Markku Pasanen, Olavi Pelkonen, Carcinogenesis GeneticsCytochrome P450ia GeneGene CharacterizationMolecular GeneticsPharmacotherapy	1990	108
Immunocytochemical localization of cytochrome P-450 in hepatic and extra-hepatic tissues of the rat with a monoclonal antibody against cytochrome P-450 c John R. Foster, Clifford R. Elcombe, Alan R. Boobis, Biochemical Pharmacology HepatologyBiochemistryNatural SciencesLiver PhysiologyPathology	1986	102
TMC–MCC (N-trimethyl chitosan–mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines Burcu Sayın, Satyanarayana Somavarapu, Xiong Wei Li, European Journal of Pharmaceutical Sciences VaccinationNanomedicineMucosal VaccinationEngineeringImmunology	2009	98
Therapeutic botulinum type a toxin: Factors affecting potency Kay McLellan, Rose E. Gaines Das, Theresa Ekong, Toxicon ToxinologyMedicineToxicologyPlant ToxinPharmacology	1996	93
Effect of Vaccination with Carrier Protein on Response to Meningococcal C Conjugate Vaccines and Value of Different Immunoassays as Predictors of Protection M Burrage, A. Robinson, Ray Borrow, Infection and Immunity	2002	91

Page 1